Bioanalysis Zone

European regulatory perspective on pediatric physiologically based pharmacokinetic models

Physiologically based pharmacokinetic (PBPK) models offer a mechanistic understanding of the disposition of the drug in the body. When well informed and conducted, this may lead to more efficient clinical studies in the vulnerable pediatric population. A review of pediatric submissions to European regulatory authorities has shown a limited number of recent examples.
To view restricted content, please:

Leave A Comment